Medication-Related Osteonecrosis of the Jaw (MRONJ) is a rare but serious complication associated with anti-resorptive drugs, such as bisphosphonates and denosumab and antiangiogenic agents
These are used to treat osteoporosis, bone metastases, and certain cancers.
MRONJ is characterised by persistent exposed bone in the jaw for more than 8 weeks in patients taking these medications. Patient shouldn’t have history of radiation therapy to the jaws. ( To rule out osteoradionecrosis)
Common Risk Factors
-
Tooth extraction or other invasive dental procedures
-
Untreated periodontitis
-
Poor oral hygiene
-
Long-term or intravenous antiresorptive therapy
-
Smoking, diabetes, and corticosteroid use
The jaw has a high rate of bone remodelling. These medications suppress normal bone turnover, making healing difficult after trauma or infection and increasing the risk of bone necrosis.
Prevention
-
Taking a thorough medication history.
-
Treating periodontal disease and oral infections before starting therapy.
-
Promoting excellent oral hygiene and regular dental check-ups.
-
Avoiding unnecessary invasive procedures whenever possible.
Although MRONJ is uncommon, early identification of at-risk patients and preventive dental care can significantly reduce its occurrence.
There are so many complications related to many drugs, so taking complete medical history is very important.
Comment your opinion and thoughts in comment section.
MBH/PS